0
     

Report Added
Report already added
Analgesics in China

Analgesics in China

Both systemic analgesics and topical analgesics/anaesthetic were negatively impacted by the fall of in-store traffic to offline chemists/pharmacies during COVID-19 in 2020, but are on the path to steady recovery in 2021. Sales of systemic analgesics slumped in 2020 due to the stringent measures that were taken to monitor retail sales of COVID-19-related products. Therefore, with the easing of restrictions and the lifting of suspension measures when the pandemic was under control, demand for syst...

Euromonitor International's Analgesics in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Analgesics in China

ANALGESICS IN CHINA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Analgesics sees recovery due to lifting of the suspensions of retail sales seen during COVID-19
Systemic analgesics does not reach pre-crisis levels
Topical analgesics/anaesthetic rebounds as consumers resume daily activities
PROSPECTS AND OPPORTUNITIES
Centralised drug procurement expected to lower the price of paediatric analgesics
Higher price per transaction will propel value growth in topical analgesics/anaesthetic
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN CHINA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Distribution of Consumer Health by Format: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format and Category: % Value 2021
Table 15 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Report Title: Analgesics in China


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW